{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F95-detecting-amyloid-tau-in-alzheimers-disease-september-2020-Y6QglkdB","width":444,"version":"1.0","type":"rich","title":"95 - Detecting Amyloid & Tau in Alzheimer's Disease: September 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/9d453e2b-39b1-49ba-b3b6-e88905781857/slide61.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c4b7d256-b65b-4581-93d4-9f327d5ac405\" height=\"200\" width=\"100%\" title=\"95 - Detecting Amyloid &amp; Tau in Alzheimer&apos;s Disease: September 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this half-hour episode, Judy goes through September 2020 papers that look at diagnosing or characterizing Alzheimer's disease based on the detection of the proteins amyloid and tau in the brain and other structures. Topics include conventional and novel neuroimaging techniques, deep learning methods and retinal amyloid-beta. Tune in to find out more! \n\nSections in this episode: \n\nPET \nDeep Learning Methods 1:06 \nStandardized Uptake Value Ratios 4:00 \nMild Cognitive Impairment 12:05 \nNeuropsychological Tests and Executive Function 15:28  \nOther 17:49 \n\nNon-PET \nRetinal Amyloid-Beta 21:22 \nOther 24:11 "}